Hemo clinical plan2 Jan 2026 15:21
Anybody noticed the following clinical plan on their website...it seems they are treating ALL and AML now...this seems new and exciting.
Clinical Plan:
Initial clinical study to be conducted in relapsed or refractory FLT3+ AML and ALL patients pre-qualified for HSC/HP transplantation to obtain preliminary data on safety (dose escalation), tolerability and Ph II dose (expected initiation in 2025/2026)
The study will be expanded into pediatric R/R AML and KMT2A rearranged acute lymphoblastic leukemia (ALL)
Potential upside for early signal of activity demonstrated as:
Elimination of malignant cells (FLT3+ AML)
Elimination of HSC/HP (myeloablative conditioning)